Treatment Patterns of Pediatric Patients with Atopic Dermatitis: A Claims Data Analysis.

[1]  H. Brandling-Bennett,et al.  Pediatric dermatology workforce in the United States , 2018, Pediatric dermatology.

[2]  S. Feldman,et al.  Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis , 2018, JAMA dermatology.

[3]  S. Feldman,et al.  An assessment of the use of antihistamines in the management of atopic dermatitis , 2018, Journal of the American Academy of Dermatology.

[4]  J. C. Jaworski,et al.  A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns , 2018, Dermatology and Therapy.

[5]  S. Feldman,et al.  Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace , 2018, The Journal of dermatological treatment.

[6]  F. Plessow,et al.  Increased attention‐deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use , 2018, Allergy.

[7]  W. K. Chin.  Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all , 2018, Journal of clinical pharmacy and therapeutics.

[8]  S. Feldman,et al.  Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012. , 2018, Journal of drugs in dermatology : JDD.

[9]  C. Flohr,et al.  Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement , 2018, The British journal of dermatology.

[10]  M. Lebwohl,et al.  A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis , 2017, Journal of the American Academy of Dermatology.

[11]  F. van Hunsel,et al.  Adverse drug reactions of montelukast in children and adults , 2017, Pharmacology research & perspectives.

[12]  C. Flohr,et al.  Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey , 2017, Journal of the American Academy of Dermatology.

[13]  Ai-Young Lee.  Is Montelukast Benefical in Children With Atopic Dermatitis? , 2016, Allergy, asthma & immunology research.

[14]  S. Feldman,et al.  Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers , 2015, Pediatrics.

[15]  S. Nutten.  Atopic Dermatitis: Global Epidemiology and Risk Factors , 2015, Annals of Nutrition and Metabolism.

[16]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. , 2014, Journal of the American Academy of Dermatology.

[17]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. , 2014, Journal of the American Academy of Dermatology.

[18]  J. Silverberg,et al.  Associations of Childhood Eczema Severity: A US Population-Based Study , 2014, Dermatitis : contact, atopic, occupational, drug.

[19]  J. Schmitt,et al.  Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. , 2014, The Journal of allergy and clinical immunology.

[20]  M. Boguniewicz,et al.  Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States. , 2013, The Journal of pediatrics.

[21]  K. H. Kim.  Overview of atopic dermatitis , 2013, Asia Pacific allergy.

[22]  J. Ring,et al.  Guidelines for treatment of atopic eczema (atopic dermatitis) Part II , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  J. Ring,et al.  Guidelines for treatment of atopic eczema (atopic dermatitis) Part I , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  K. Rhodes,et al.  Auditing access to specialty care for children with public insurance. , 2011, The New England journal of medicine.

[25]  A. Skinner,et al.  Effects of insurance status on children's access to specialty care: a systematic review of the literature , 2007, BMC Health Services Research.

[26]  V. Sharma,et al.  Atopic Dermatitis in Children in the United States, 1997–2004: Visit Trends, Patient and Provider Characteristics, and Prescribing Patterns , 2007, Pediatrics.

[27]  S. Feldman,et al.  Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. , 2007, Journal of the American Academy of Dermatology.

[28]  Hywel C Williams,et al.  Clinical practice. Atopic dermatitis. , 2005, The New England journal of medicine.

[29]  B. Niggemann,et al.  The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. , 2004, The Journal of allergy and clinical immunology.

[30]  S. G. Pollock.  Access of Medicaid recipients to outpatient care. , 1994, The New England journal of medicine.

[31]  R. Antaya,et al.  Pediatric dermatology: past, present, and future. , 2015, Pediatric dermatology.

[32]  J. Resneck,et al.  Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. , 2004, Journal of the American Academy of Dermatology.

[33]  R. Derlet,et al.  Access of Medicaid recipients to outpatient care. , 1994, The New England journal of medicine.